We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Magnetically Levitated Rotor Helps Heart Pump Blood

By HospiMedica International staff writers
Posted on 24 Sep 2008
A new left ventricle assist system (LVAS) levitates in the middle of the heart chamber, never touching the walls, consistently pushing blood from the heart to the body.

The DuraHeart LVAS is a third-generation rotary blood pump designed for long-term patient support. More...
It incorporates a centrifugal flow rotary pump with a magnetically levitated impeller to pump blood from the heart around the body. The magnetically levitating impeller--shaped like a flat magnetic disc the size of hockey puck--acts as a paddlewheel, turning constantly as it is suspended in a magnetic field coupled to a turning motor within the pump housing. This expels the blood into a flexible artificial blood vessel, called the outflow conduit, which is connected to the ascending aorta. As a result, the DuraHeart may cause less damage to blood cells and be less likely to allow dangerous blood clots to form, compared with other heart-assisting devices that use mechanical pumps. During the implantation procedure, the surgeon diverts blood flow from the ailing left ventricle of the heart into a titanium tube that leads into the pumping chamber. The DuraHeart a product of Terumo Heart (Ann Arbor, MI, USA), has received the European Community (EC) marking, and is currently undergoing clinical trails in the United Sates.

"This trial will test the DuraHeart's potential to overcome some of the issues that have been seen with other devices, including hemolysis caused by shear stress on red blood cells, and clotting risk caused by blood that does not circulate rapidly enough from all areas of the chamber,” said surgeon Francis Pagani, M.D., Ph.D. of the University of Michigan (Ann Arbor, MI, USA) cardiovascular center, who is co-leader of the U.S. clinical trial of the DuraHeart. "It also remains to be seen if this device offers superior durability, which might make it useful as a destination therapy that could remove the need for a heart transplant.”

Related Links:
Terumo Heart
University of Michigan



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.